Suspension of trading
Valuation Decoy Therapeutics Inc. Börse Stuttgart
Stocks
FP11
US79400X6022
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.104 EUR | -3.96% |
|
+704.15% | +435.17% |
| 07-10 | Decoy Therapeutics Files to Register Up to 3.77 Million Shares for Resale | MT |
| 06-30 | Top Premarket Decliners | MT |
Company Valuation: Decoy Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22.39 | 3.485 | 2.56 | 2.652 | 4.142 | 3.144 | - | - |
| Change | - | -84.43% | -26.55% | 3.58% | 56.21% | -24.1% | - | - |
| Enterprise Value (EV) | 22.39 | 3.485 | 2.56 | 2.652 | 4.142 | 3.144 | 3.144 | 3.144 |
| Change | - | -84.43% | -26.55% | 3.58% | 56.21% | -24.1% | 0% | 0% |
| P/E | -1.6x | - | -0.17x | -0.32x | -0.06x | -0.46x | -0.31x | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0x | 0x | -0x | - |
| Capitalization / Revenue | 12,167,670x | - | - | - | - | - | - | - |
| EV / Revenue | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | - | - | - | - | -0x | -0.28x | -0.18x | -0.1x |
| EV / FCF | - | - | - | - | - | -0.32x | -0.19x | -0.11x |
| FCF Yield | - | - | - | - | - | -309% | -518% | -891% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -11,160 | - | -5,530 | -1,042 | -129.1 | -12.96 | -19.32 | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales | 1.84 | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | - | - | - | - | -12.61 | -11.1 | -17.7 | -30.5 |
| Net income 1 | -12.77 | -31.61 | -12.54 | -5.576 | -12.52 | -10.7 | -17.8 | - |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 17,841.586 | 2,203.200 | 936.000 | 331.200 | 7.786 | 5.910 | 5.910 | 5.910 |
| Nbr of stocks (in thousands) | 1.26 | 1.58 | 2.74 | 8.01 | 532 | 532 | - | - |
| Announcement Date | 3/10/22 | 3/27/23 | 3/22/24 | 3/21/25 | 3/31/26 | - | - | - |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.57x | 6.33x | 13.8x | 1.56% | 54.88B | |
| 32.72x | 8.29x | 25.68x | 0.06% | 54.63B | |
| -44.31x | 14.51x | -42.32x | -.--% | 25.06B | |
| -18.2x | 4.33x | -7.58x | -.--% | 23.14B | |
| 25x | 4.9x | 12.9x | -.--% | 19.87B | |
| 24.48x | 4.79x | 15.58x | -.--% | 17.55B | |
| 49.34x | 20.07x | 51.69x | 0.07% | 16.5B | |
| -539.24x | 37.99x | -4235.53x | -.--% | 15.75B | |
| 17.75x | 5.16x | 12.01x | -.--% | 14.2B | |
| Average | -47.99x | 11.82x | -461.53x | 0.19% | 26.84B | |
| Weighted average by Cap. | -21.17x | 10.13x | -265.84x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DCOY Stock
- FP11 Stock
- Valuation Decoy Therapeutics Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
